Clinical Trial Update: Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating anlotinib hydrochloride plus liposomal doxorubicin for locally advanced or metastatic soft tissue sarcoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Anlotinib hydrochloride (anlotinib)
• liposomal doxorubicin (doxorubicin liposomal)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Sarcoma | Phase 2 | Status: UNKNOWN